What is a PSMA PET scan? Know its uses and risks
A PSMA PET scan is an advanced imaging test that detects prostate cancer cells by targeting a protein called prostate-specific membrane antigen (PSMA). Learn more
A PSMA PET scan is an advanced imaging test that detects prostate cancer cells by targeting a protein called prostate-specific membrane antigen (PSMA). Learn more
A Digital Rectal Examination (DRE) is a quick physical exam that helps doctors check the prostate for lumps, hardness, enlargement, or other changes that could be linked to prostate cancer. Learn more
Prostate cancer is one of the most common cancers affecting men worldwide, and age is its strongest risk factor. If you’ve searched, “What percentage of men over 60 have prostate cancer?”, you’ve probably noticed different numbers from different websites. Learn more
Intraductal Carcinoma of the Prostate (IDC-P) is an aggressive prostate cancer finding that is strongly associated with high-grade disease, larger tumor volume, and a greater risk of recurrence. Learn more
No, a prostate biopsy does not cause or spread prostate cancer in the vast majority of patients. While extremely rare cases of cancer cell seeding have been reported in medical literature, decades of research show that the benefits of diagnosing prostate cancer far outweigh this exceptionally small risk. Learn more.
Cribriform prostate cancer is not a separate type of prostate cancer but a microscopic growth pattern that pathologists identify on biopsy or prostate tissue. Learn more
If you have been told that you are being referred under the “2-week rule” for prostate cancer, it can understandably sound alarming. Learn more.
Prostate cancer recurrence means the cancer has returned after initial treatment, either as a rising PSA level (biochemical recurrence), within the prostate area, nearby lymph nodes, or elsewhere in the body. Early detection through PSA testing and modern imaging such as PSMA PET/CT allows doctors to identify recurrence sooner and choose treatments that can delay progression and improve long-term outcomes. Hearing that your prostate cancer has returned can feel overwhelming. However, a recurrence does not necessarily mean the disease is incurable. Thanks to advances in PSA monitoring, PSMA PET imaging, precision radiotherapy, hormone therapy, and targeted treatments, many men live long and active lives after recurrence. What Is Prostate Cancer Recurrence? Prostate cancer recurrence occurs when cancer returns after treatment that was originally intended to eliminate or control the disease. It can happen months or even many years after surgery, radiation therapy, or other treatments. One of the most important things to understand is that recurrence doesn’t always cause symptoms initially. In many cases, the first sign is a rising prostate-specific antigen (PSA) level, long before scans show visible cancer. This is known as biochemical recurrence (BCR). Doctors generally classify recurrence into three categories: How Common Is Prostate Cancer Recurrence? Prostate cancer Recurrence is more common than many people realize. Studies suggest that approximately 20% to 40% of men treated with surgery or radiation eventually develop biochemical recurrence. However, not everyone with a rising PSA develops metastatic disease, and many men remain free of symptoms for years with appropriate monitoring or treatment. The chance of recurrence depends on several factors, including: What Causes Prostate Cancer Recurrence? Recurrence usually happens because microscopic cancer cells remained in the body after initial treatment. These cells may have been too small to detect on imaging or blood tests. Common reasons include: It’s important to remember that recurrence does not necessarily mean the original treatment failed. Modern treatments eliminate visible disease very effectively, but microscopic cells can sometimes survive despite excellent care. Understanding Biochemical Recurrence (BCR) Biochemical recurrence is the earliest and most common form of recurrence. Instead of seeing cancer on a scan, doctors first notice that PSA begins rising again. The definition depends on the original treatment. After Radical Prostatectomy Because the prostate has been removed, PSA should become almost undetectable. Biochemical recurrence is generally defined as: After Radiation Therapy Some prostate tissue remains after radiation, so PSA never falls completely to zero. Doctors commonly use the Phoenix definition: Signs and Symptoms of Prostate Cancer Recurrence Many men experience no symptoms during the early stages. As recurrence progresses, symptoms may include: Because symptoms often appear late, routine PSA monitoring after treatment is essential. How Doctors Diagnose Recurrence Once PSA begins increasing, doctors use additional tests to determine where the cancer has returned. These may include: PSA Testing The PSA trend is often more informative than a single value. Doctors evaluate: A rapidly rising PSA usually indicates a more aggressive recurrence. PSMA PET/CT One of the biggest advances in prostate cancer care is PSMA PET imaging. Unlike conventional CT or bone scans, PSMA PET can detect very small areas of recurrent cancer, often at much lower PSA levels, allowing doctors to tailor treatment earlier. MRI Multiparametric MRI is particularly useful for identifying local recurrence in the prostate bed after surgery. Biopsy If imaging suggests a local recurrence, a biopsy may sometimes be performed to confirm the diagnosis before further treatment. Treatment Options for Prostate Cancer Recurrence Treatment depends on where the recurrence is located, how quickly PSA is rising, previous treatments, and the patient’s overall health. Common options include: Many recurrences remain treatable for years, and management is increasingly personalized. Survival Rates After Prostate Cancer Recurrence A diagnosis of recurrence does not automatically mean a poor prognosis. Many men with recurrent prostate cancer live for years or even decades, particularly when the recurrence is detected early and treated appropriately. The outlook depends on several factors, including: One of the strongest predictors of outcome is PSA doubling time. Men whose PSA doubles very rapidly (for example, in less than 6–10 months) generally have a higher risk of developing metastatic disease than those with a slower PSA increase. Studies have consistently shown that PSA kinetics help guide decisions about the timing and intensity of treatment. Fortunately, advances in PSMA PET/CT imaging, precision radiotherapy, and newer hormone therapies mean that many recurrences are detected much earlier than they were a decade ago, allowing treatment before symptoms develop. These advances have significantly improved disease control for many patients.Sources: American Cancer Society; ASCO Educational Book; European Association of Urology (EAU) Guidelines. Can Prostate Cancer Recurrence Be Prevented? There is currently no guaranteed way to prevent prostate cancer from recurring, but there are steps that may reduce the risk of progression and help detect recurrence as early as possible. 1. Never Skip PSA Follow-Up The single most important recommendation after treatment is to attend every scheduled PSA test. Typical follow-up schedules include: Because PSA often rises years before symptoms appear, routine monitoring allows doctors to intervene early. 2. Maintain a Healthy Weight Several studies suggest that obesity is associated with a higher risk of aggressive prostate cancer and poorer outcomes after treatment. Maintaining a healthy body weight through regular exercise and a balanced diet may support overall health and reduce the risk of disease progression. 3. Stay Physically Active Regular physical activity offers multiple benefits, including: The American Cancer Society recommends regular exercise tailored to an individual’s abilities and medical condition. 4. Eat a Heart-Healthy Diet While no specific diet has been proven to prevent recurrence, many experts recommend: A Mediterranean-style eating pattern is commonly recommended because it supports overall health and may reduce inflammation. 5. Don’t Smoke Smoking has been associated with higher prostate cancer mortality and poorer treatment outcomes. Quitting smoking improves overall survival and reduces the risk of several other cancers and cardiovascular diseases. 6. Discuss Clinical Trials Men with recurrent prostate cancer may qualify for clinical trials evaluating: Clinical trials often provide access to emerging
Yes, exercise can have a meaningful impact on men with prostate cancer, particularly on physical fitness, fatigue, muscle strength, body weight, and quality of life. Learn more
Black men have the highest prostate cancer incidence and mortality rates worldwide due to a complex combination of inherited genetic factors, tumour biology, healthcare inequalities, environmental influences, and delayed diagnosis, not because of a single cause. Learn more